Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:24:47.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the former content with an error page. This change blocks access to the study details, contacts, locations, and related documents that users expect to see on the page.
    Difference
    19%
    Check dated 2026-09-19T22:03:22.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added, replacing the prior Revision: v3.6.5. This reflects a minor update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-08-29T18:54:06.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small version update to the page.
    Difference
    0.1%
    Check dated 2026-08-08T15:33:47.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The revision label on the page was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new build of the page.
    Difference
    0.1%
    Check dated 2026-07-25T07:46:23.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.2 to v3.6.3, indicating a minor platform update. No study content or visible details were altered.
    Difference
    0.1%
    Check dated 2026-07-03T23:37:55.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.